PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
21.67%
Net income growth at 50-75% of ZETA's 40.68%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
19.81%
Some D&A expansion while ZETA is negative at -1.61%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.12%
Negative yoy working capital usage while ZETA is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
117.43%
Inventory growth of 117.43% while ZETA is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
No Data
No Data available this quarter, please select a different quarter.
-51.91%
Negative yoy usage while ZETA is 100.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
No Data
No Data available this quarter, please select a different quarter.
16.18%
Operating cash flow growth at 75-90% of ZETA's 20.83%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-87.01%
Negative yoy CapEx while ZETA is 14.14%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
109.33%
Purchases growth of 109.33% while ZETA is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
No Data
No Data available this quarter, please select a different quarter.
-625.00%
Both yoy lines negative, with ZETA at -39.54%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
29.37%
We have mild expansions while ZETA is negative at -18.84%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-5.89%
Negative yoy issuance while ZETA is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-149.33%
Both yoy lines negative, with ZETA at -23.83%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.